These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

960 related items for PubMed ID: 26992223

  • 1. MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt/β-catenin signaling in breast cancer.
    Tan Z, Zheng H, Liu X, Zhang W, Zhu J, Wu G, Cao L, Song J, Wu S, Song L, Li J.
    Oncotarget; 2016 Apr 26; 7(17):24076-87. PubMed ID: 26992223
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway.
    Ge C, Wu S, Wang W, Liu Z, Zhang J, Wang Z, Li R, Zhang Z, Li Z, Dong S, Wang Y, Xue Y, Yang J, Tan Q, Wang Z, Song X.
    Oncotarget; 2015 May 10; 6(13):10964-77. PubMed ID: 25844602
    [Abstract] [Full Text] [Related]

  • 6. MiR-301a is activated by the Wnt/β-catenin pathway and promotes glioma cell invasion by suppressing SEPT7.
    Yue X, Cao D, Lan F, Pan Q, Xia T, Yu H.
    Neuro Oncol; 2016 Sep 10; 18(9):1288-96. PubMed ID: 27006177
    [Abstract] [Full Text] [Related]

  • 7. Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling.
    Ma F, Zhang J, Zhong L, Wang L, Liu Y, Wang Y, Peng L, Guo B.
    Gene; 2014 Feb 10; 535(2):191-7. PubMed ID: 24315818
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.
    Jiang Q, He M, Guan S, Ma M, Wu H, Yu Z, Jiang L, Wang Y, Zong X, Jin F, Wei M.
    Tumour Biol; 2016 Apr 10; 37(4):5001-11. PubMed ID: 26537584
    [Abstract] [Full Text] [Related]

  • 9. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY, Xue M, Zhang QC, Su CF.
    Oncotarget; 2017 Feb 28; 8(9):15507-15519. PubMed ID: 28099945
    [Abstract] [Full Text] [Related]

  • 10. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.
    Jiang JX, Sun CY, Tian S, Yu C, Chen MY, Zhang H.
    Tumour Biol; 2016 Oct 28; 37(10):13893-13902. PubMed ID: 27485116
    [Abstract] [Full Text] [Related]

  • 11. MiR-182 promotes prostate cancer progression through activating Wnt/β-catenin signal pathway.
    Wang D, Lu G, Shao Y, Xu D.
    Biomed Pharmacother; 2018 Mar 28; 99():334-339. PubMed ID: 29353209
    [Abstract] [Full Text] [Related]

  • 12. Long non-coding RNA RP11-283G6.5 confines breast cancer development through modulating miR-188-3p/TMED3/Wnt/β-catenin signalling.
    Pei J, Zhang S, Yang X, Han C, Pan Y, Li J, Wang Z, Sun C, Zhang J.
    RNA Biol; 2021 Oct 15; 18(sup1):287-302. PubMed ID: 34130584
    [Abstract] [Full Text] [Related]

  • 13. IL-3R-alpha blockade inhibits tumor endothelial cell-derived extracellular vesicle (EV)-mediated vessel formation by targeting the β-catenin pathway.
    Lombardo G, Gili M, Grange C, Cavallari C, Dentelli P, Togliatto G, Taverna D, Camussi G, Brizzi MF.
    Oncogene; 2018 Mar 15; 37(9):1175-1191. PubMed ID: 29238040
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
    Zhang Y, Guo L, Li Y, Feng GH, Teng F, Li W, Zhou Q.
    Mol Cancer; 2018 Jan 05; 17(1):1. PubMed ID: 29304823
    [Abstract] [Full Text] [Related]

  • 15. miR-302b inhibits tumorigenesis by targeting EphA2 via Wnt/ β-catenin/EMT signaling cascade in gastric cancer.
    Huang J, He Y, Mcleod HL, Xie Y, Xiao D, Hu H, Chen P, Shen L, Zeng S, Yin X, Ge J, Li L, Tang L, Ma J, Chen Z.
    BMC Cancer; 2017 Dec 22; 17(1):886. PubMed ID: 29273006
    [Abstract] [Full Text] [Related]

  • 16. A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer.
    Kim do Y, Park EY, Chang E, Kang HG, Koo Y, Lee EJ, Ko JY, Kong HK, Chun KH, Park JH.
    Oncotarget; 2016 Mar 22; 7(12):14791-802. PubMed ID: 26895471
    [Abstract] [Full Text] [Related]

  • 17. Downregulation of miR-432 activates Wnt/β-catenin signaling and promotes human hepatocellular carcinoma proliferation.
    Jiang N, Chen WJ, Zhang JW, Xu C, Zeng XC, Zhang T, Li Y, Wang GY.
    Oncotarget; 2015 Apr 10; 6(10):7866-79. PubMed ID: 25797263
    [Abstract] [Full Text] [Related]

  • 18. Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer.
    Yu L, Li X, Li H, Chen H, Liu H.
    Tumour Biol; 2016 Oct 10; 37(10):13821-13829. PubMed ID: 27481517
    [Abstract] [Full Text] [Related]

  • 19. TUG1 knockdown inhibits the tumorigenesis and progression of prostate cancer by regulating microRNA-496/Wnt/β-catenin pathway.
    Li G, Yang J, Chong T, Huang Y, Liu Y, Li H.
    Anticancer Drugs; 2020 Jul 10; 31(6):592-600. PubMed ID: 32427740
    [Abstract] [Full Text] [Related]

  • 20. MiR-200c/FUT4 axis prevents the proliferation of colon cancer cells by downregulating the Wnt/β-catenin pathway.
    Cong J, Gong J, Yang C, Xia Z, Zhang H.
    BMC Cancer; 2021 Jan 04; 21(1):2. PubMed ID: 33397320
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.